Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
Mesenchymal stem cells (MSCs) loaded with oncolytic viruses are presently being investigated as a new modality of advanced/metastatic tumors treatment and enhancement of virotherapy. MSCs can, however, either promote or suppress tumor growth. To address the critical question of how MSCs loaded with...
Asıl Yazarlar: | Mahasa, K, De Pillis, L, Ouifki, R, Eladdadi, A, Maini, P, Yoon, A, Yun, C |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Springer Nature
2020
|
Benzer Materyaller
-
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach.
Yazar:: Khaphetsi Joseph Mahasa, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01) -
A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept
Yazar:: Khaphetsi Joseph Mahasa, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01) -
Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis
Yazar:: Joseph Malinzi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01) -
Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
Yazar:: Alberto Reale, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01) -
Oncolytic virotherapy
Yazar:: Daniel Cervantes-García;, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)